| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CASC | Cascadian Therapeutics, Inc. | Viswanathan Ravi | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:45 PM | |
| CASC | Cascadian Therapeutics, Inc. | Sonsini Peter W. | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:45 PM | |
| CASC | Cascadian Therapeutics, Inc. | SANDELL SCOTT D | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:44 PM | |
| CASC | Cascadian Therapeutics, Inc. | Sakoda Jon | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:44 PM | |
| CASC | Cascadian Therapeutics, Inc. | MOTT DAVID M | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:44 PM | |
| CASC | Cascadian Therapeutics, Inc. | MAKOWER JOSHUA | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:43 PM | |
| CASC | Cascadian Therapeutics, Inc. | Florence Anthony A. Jr. | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:43 PM | |
| CASC | Cascadian Therapeutics, Inc. | BASKETT FOREST | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:42 PM | |
| CASC | Cascadian Therapeutics, Inc. | BARRIS PETER J | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:42 PM | |
| CASC | Cascadian Therapeutics, Inc. | NEA 15 GP, LLC | 10% Owner | Feb 20, 2018 | Option Exercise | $3.30 | 1,818,000 | 5,999,400 | 10,882,574 | Feb 22, 2018, 04:41 PM | |
| CASC | Cascadian Therapeutics, Inc. | Walker Luke Nathaniel | SVP, Clinical Development | Jan 11, 2018 | Option Exercise | $3.92 | 637 | 2,497 | 5,303 | Jan 16, 2018, 05:29 PM | |
| CASC | Cascadian Therapeutics, Inc. | PETERSON SCOTT ROBERT | Chief Scientific Officer | Jan 11, 2018 | Option Exercise | $3.92 | 923 | 3,618 | 3,639 | Jan 16, 2018, 05:28 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Jan 11, 2018 | Option Exercise | $3.92 | 3,429 | 13,442 | 56,787 | Jan 16, 2018, 05:26 PM | |
| CASC | Cascadian Therapeutics, Inc. | EASTLAND JULIA MARIE | CFO & CBO | Jan 11, 2018 | Option Exercise | $3.92 | 923 | 3,618 | 5,237 | Jan 16, 2018, 05:25 PM | |
| CASC | Cascadian Therapeutics, Inc. | Christianson Gary | Chief Operating Officer | Jan 11, 2018 | Option Exercise | $3.92 | 923 | 3,618 | 6,515 | Jan 16, 2018, 05:24 PM | |
| CASC | Cascadian Therapeutics, Inc. | SPIEGELMAN DANIEL K | Director | Sep 24, 2017 | Option Exercise | $3.94 | 594 | 2,340 | 21,006 | Sep 26, 2017, 05:22 PM | |
| CASC | Cascadian Therapeutics, Inc. | LOVE TED W | Director | Sep 24, 2017 | Option Exercise | $3.94 | 594 | 2,340 | 37,394 | Sep 26, 2017, 05:21 PM | |
| CASC | Cascadian Therapeutics, Inc. | James Steven P | Director | Sep 24, 2017 | Option Exercise | $3.94 | 594 | 2,340 | 13,677 | Sep 26, 2017, 05:20 PM | |
| CASC | Cascadian Therapeutics, Inc. | HENNEY CHRISTOPHER S | Director | Sep 24, 2017 | Option Exercise | $3.94 | 594 | 2,340 | 60,185 | Sep 26, 2017, 05:19 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Aug 11, 2017 | Buy | $3.73 | 5,500 | 20,542 | 49,716 | Aug 14, 2017, 05:12 PM | |
| CASC | Cascadian Therapeutics, Inc. | SPIEGELMAN DANIEL K | Director | Jun 24, 2017 | Option Exercise | $3.78 | 2,265 | 8,562 | 19,225 | Jun 27, 2017, 05:41 PM | |
| CASC | Cascadian Therapeutics, Inc. | LOVE TED W | Director | Jun 24, 2017 | Option Exercise | $3.78 | 2,265 | 8,562 | 35,613 | Jun 27, 2017, 05:41 PM | |
| CASC | Cascadian Therapeutics, Inc. | James Steven P | Director | Jun 24, 2017 | Option Exercise | $3.78 | 2,265 | 8,562 | 11,896 | Jun 27, 2017, 05:40 PM | |
| CASC | Cascadian Therapeutics, Inc. | HENNEY CHRISTOPHER S | Director | Jun 24, 2017 | Option Exercise | $3.78 | 2,265 | 8,562 | 58,404 | Jun 27, 2017, 05:39 PM | |
| CASC | Cascadian Therapeutics, Inc. | Fyfe Gwen A. | Director | Jun 24, 2017 | Option Exercise | $3.78 | 2,265 | 8,562 | 10,125 | Jun 27, 2017, 05:38 PM | |
| CASC | Cascadian Therapeutics, Inc. | SPIEGELMAN DANIEL K | Director | Jun 12, 2017 | Option Exercise | $3.34 | 537 | 1,794 | 12,432 | Jun 13, 2017, 04:42 PM | |
| CASC | Cascadian Therapeutics, Inc. | LOVE TED W | Director | Jun 12, 2017 | Option Exercise | $3.34 | 537 | 1,794 | 28,820 | Jun 13, 2017, 04:41 PM | |
| CASC | Cascadian Therapeutics, Inc. | James Steven P | Director | Jun 12, 2017 | Option Exercise | $3.34 | 537 | 1,794 | 5,103 | Jun 13, 2017, 04:40 PM | |
| CASC | Cascadian Therapeutics, Inc. | HENNEY CHRISTOPHER S | Director | Jun 12, 2017 | Option Exercise | $3.34 | 537 | 1,794 | 51,611 | Jun 13, 2017, 04:39 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | May 12, 2017 | Buy | $4.00 | 2,800 | 11,192 | 44,216 | May 16, 2017, 05:43 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Mar 31, 2017 | Buy | $4.11 | 2,000 | 8,229 | 41,416 | Apr 04, 2017, 05:39 PM | |
| CASC | Cascadian Therapeutics, Inc. | Fyfe Gwen A. | Director | Mar 28, 2017 | Buy | $4.12 | 1,666 | 6,857 | 3,332 | Mar 30, 2017, 06:34 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Mar 20, 2017 | Buy | $3.93 | 1,000 | 3,927 | 39,416 | Mar 21, 2017, 08:09 PM | |
| CASC | Cascadian Therapeutics, Inc. | James Steven P | Director | Mar 12, 2017 | Option Exercise | $4.35 | 1,164 | 5,063 | 3,492 | Mar 14, 2017, 02:19 PM | |
| CASC | Cascadian Therapeutics, Inc. | LOVE TED W | Director | Feb 02, 2017 | Buy | $4.24 | 23,000 | 97,520 | 27,209 | Feb 03, 2017, 06:21 PM | |
| CASC | Cascadian Therapeutics, Inc. | HENNEY CHRISTOPHER S | Director | Jan 30, 2017 | Buy | $4.11 | 25,324 | 103,973 | 50,000 | Feb 01, 2017, 04:38 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Jan 27, 2017 | Buy | $3.76 | 20,500 | 77,039 | 38,416 | Jan 31, 2017, 04:55 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Aug 17, 2016 | Buy | $1.15 | 45,000 | 51,745 | 107,500 | Aug 18, 2016, 05:16 PM | |
| CASC | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Jun 28, 2016 | Buy | $0.80 | 62,500 | 50,000 | 62,500 | Jun 28, 2016, 05:36 PM | |
| ONTY | Oncothyreon Inc. | LOVE TED W | Director | Sep 05, 2015 | Option Exercise | $3.25 | 4,336 | 14,092 | 13,005 | Sep 09, 2015, 05:07 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 13, 2015 | Option Exercise | $3.88 | 4,011 | 15,563 | 52,675 | Jun 16, 2015, 05:00 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Jun 13, 2015 | Option Exercise | $3.88 | 4,011 | 15,563 | 59,557 | Jun 16, 2015, 04:55 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Jun 13, 2014 | Option Exercise | $3.88 | 4,011 | 15,563 | 135,807 | Jun 16, 2015, 04:53 PM | |
| ONTY | Oncothyreon Inc. | HAUSMAN DIANA | Chief Medical Officer | Jun 01, 2015 | Buy | $4.65 | 5,747 | 26,724 | 5,747 | Jun 03, 2015, 04:45 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 25, 2015 | Buy | $1.63 | 10,000 | 16,271 | 30,644 | Apr 02, 2015, 05:11 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 26, 2015 | Buy | $1.59 | 10,000 | 15,856 | 40,644 | Apr 02, 2015, 05:11 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 25, 2015 | Buy | $1.63 | 10,000 | 16,271 | 30,644 | Apr 01, 2015, 07:28 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 26, 2015 | Buy | $1.59 | 10,000 | 15,856 | 40,644 | Apr 01, 2015, 07:28 PM | |
| ONTY | Oncothyreon Inc. | BIOTECHNOLOGY VALUE FUND L P | See Explanation of Responses | Dec 17, 2014 | Buy | $1.73 | 98,298 | 170,360 | 6,362,683 | Dec 17, 2014, 06:10 PM | |
| ONTY | Oncothyreon Inc. | LAMPERT MARK N | 10% Owner | Dec 15, 2014 | Buy | $1.88 | 79,434 | 149,249 | 3,243,096 | Dec 17, 2014, 06:10 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | 10% Owner | Dec 15, 2014 | Buy | $1.88 | 145,515 | 273,408 | 6,264,385 | Dec 17, 2014, 06:10 PM | |
| ONTY | Oncothyreon Inc. | BIOTECHNOLOGY VALUE FUND II LP | See Explanation of Responses | Dec 17, 2014 | Buy | $1.73 | 55,197 | 95,662 | 3,298,293 | Dec 17, 2014, 06:10 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Feb 20, 2013 | Sale | $1.96 | 12,780 | 25,054 | 24,047 | Oct 08, 2014, 04:49 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jul 10, 2013 | Sale | $1.72 | 3,403 | 5,854 | 20,644 | Oct 08, 2014, 04:49 PM | |
| ONTY | Oncothyreon Inc. | Venkatesan Jay | EVP and General Manager | Sep 23, 2014 | Buy | $2.00 | 250,000 | 500,000 | 250,000 | Sep 26, 2014, 11:33 AM | |
| ONTY | Oncothyreon Inc. | Venkatesan Jay | EVP and General Manager | Sep 23, 2014 | Option Exercise | $2.00 | 250,000 | 500,000 | 250,000 | Sep 25, 2014, 04:47 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | See Explanation of Responses | Jul 16, 2014 | Option Exercise | $3.24 | 258,230 | 836,665 | 2,412,290 | Jul 16, 2014, 07:04 PM | |
| ONTY | Oncothyreon Inc. | LAMPERT MARK N | See Explanation of Responses | Jul 16, 2014 | Option Exercise | $3.24 | 296,008 | 959,066 | 4,512,523 | Jul 16, 2014, 07:04 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Jun 07, 2014 | Option Exercise | $3.06 | 2,044 | 6,255 | 46,692 | Jun 10, 2014, 07:43 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 07, 2014 | Option Exercise | $3.06 | 2,044 | 6,255 | 36,827 | Jun 10, 2014, 07:42 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Jun 07, 2014 | Option Exercise | $3.06 | 2,044 | 6,255 | 47,526 | Jun 10, 2014, 07:40 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Jun 07, 2014 | Option Exercise | $3.06 | 2,044 | 6,255 | 123,776 | Jun 10, 2014, 07:39 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Mar 11, 2014 | Option Exercise | $3.65 | 4,838 | 17,659 | 48,736 | Mar 12, 2014, 05:04 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 11, 2014 | Option Exercise | $3.65 | 4,838 | 17,659 | 38,871 | Mar 12, 2014, 05:04 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Mar 11, 2014 | Option Exercise | $3.65 | 4,838 | 17,659 | 49,570 | Mar 12, 2014, 05:03 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Mar 11, 2014 | Option Exercise | $3.65 | 4,838 | 17,659 | 125,820 | Mar 12, 2014, 05:02 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | 10% Owner | Nov 01, 2013 | Buy | $1.78 | 129,000 | 229,620 | 4,808,531 | Nov 05, 2013, 04:56 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | 10% Owner | Aug 08, 2013 | Buy | $1.65 | 258,361 | 426,166 | 4,758,891 | Aug 12, 2013, 05:22 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | 10% Owner | Jul 31, 2013 | Buy | $1.71 | 179,743 | 307,307 | 4,555,829 | Aug 02, 2013, 04:34 PM | |
| ONTY | Oncothyreon Inc. | BVF PARTNERS L P/IL | 10% Owner | Aug 01, 2013 | Buy | $1.78 | 158,344 | 282,296 | 4,678,470 | Aug 02, 2013, 04:34 PM | |
| ONTY | Oncothyreon Inc. | WILLIAMS DOUGLAS E | Director | Jun 09, 2013 | Option Exercise | $1.86 | 1,135 | 2,111 | 19,961 | Jun 11, 2013, 05:07 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Jun 09, 2013 | Option Exercise | $1.86 | 1,135 | 2,111 | 34,222 | Jun 11, 2013, 05:06 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 09, 2013 | Option Exercise | $1.86 | 1,135 | 2,111 | 24,357 | Jun 11, 2013, 05:05 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Jun 09, 2013 | Option Exercise | $1.86 | 1,135 | 2,111 | 35,056 | Jun 11, 2013, 05:04 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Jun 09, 2013 | Option Exercise | $1.86 | 1,135 | 2,111 | 111,306 | Jun 11, 2013, 05:02 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | 10% Owner | Jun 06, 2013 | Buy | $1.78 | 82,915 | 147,663 | 4,301,360 | Jun 07, 2013, 05:36 PM | |
| ONTY | Oncothyreon Inc. | BIOTECHNOLOGY VALUE FUND II LP | See Explanation of Responses | Jun 07, 2013 | Buy | $1.83 | 116,252 | 212,788 | 4,376,086 | Jun 07, 2013, 05:36 PM | |
| ONTY | Oncothyreon Inc. | BVF INC/IL | 10% Owner | Jun 05, 2013 | Buy | $1.75 | 15,300 | 26,775 | 4,245,829 | Jun 07, 2013, 05:36 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Jun 07, 2012 | Option Exercise | $3.67 | 8,174 | 29,999 | 112,441 | Jun 08, 2012, 03:58 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Jun 07, 2012 | Option Exercise | $3.67 | 8,174 | 29,999 | 36,191 | Jun 08, 2012, 03:57 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 07, 2012 | Option Exercise | $3.67 | 8,174 | 29,999 | 25,492 | Jun 08, 2012, 03:57 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Jun 07, 2012 | Option Exercise | $3.67 | 8,174 | 29,999 | 35,357 | Jun 08, 2012, 03:56 PM | |
| ONTY | Oncothyreon Inc. | WILLIAMS DOUGLAS E | Director | Jun 07, 2012 | Option Exercise | $3.67 | 8,174 | 29,999 | 21,096 | Jun 08, 2012, 03:56 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 03, 2012 | Option Exercise | $3.51 | 2,021 | 7,094 | 17,318 | Jun 05, 2012, 06:34 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Jun 03, 2012 | Option Exercise | $3.51 | 2,021 | 7,094 | 104,267 | Jun 05, 2012, 06:33 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Jun 03, 2012 | Option Exercise | $3.51 | 2,021 | 7,094 | 28,017 | Jun 05, 2012, 06:33 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Jun 03, 2012 | Option Exercise | $3.51 | 2,021 | 7,094 | 27,183 | Jun 05, 2012, 06:33 PM | |
| ONTY | Oncothyreon Inc. | WILLIAMS DOUGLAS E | Director | Jun 03, 2012 | Option Exercise | $3.51 | 2,021 | 7,094 | 12,922 | Jun 05, 2012, 06:32 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | May 03, 2012 | Option Exercise | $4.15 | 247 | 1,025 | 29,204 | May 04, 2012, 07:07 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | May 03, 2012 | Option Exercise | $4.15 | 247 | 1,025 | 30,038 | May 04, 2012, 07:07 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | May 03, 2012 | Option Exercise | $4.15 | 247 | 1,025 | 106,288 | May 04, 2012, 07:06 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Dec 31, 2011 | Option Exercise | $7.58 | 597 | 4,525 | 105,546 | Jan 03, 2012, 03:18 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Dec 31, 2011 | Option Exercise | $7.58 | 597 | 4,525 | 29,296 | Jan 03, 2012, 03:17 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Dec 31, 2011 | Option Exercise | $7.58 | 597 | 4,525 | 28,462 | Jan 03, 2012, 03:17 PM | |
| ONTY | Oncothyreon Inc. | WILLIAMS DOUGLAS E | Director | Dec 04, 2011 | Option Exercise | $6.86 | 1,546 | 10,606 | 17,263 | Dec 07, 2011, 06:45 PM | |
| ONTY | Oncothyreon Inc. | STOUGHTON W. VICKERY | Director | Dec 04, 2011 | Option Exercise | $6.86 | 1,546 | 10,606 | 26,671 | Dec 07, 2011, 06:44 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Dec 04, 2011 | Option Exercise | $6.86 | 1,546 | 10,606 | 19,339 | Dec 07, 2011, 06:44 PM | |
| ONTY | Oncothyreon Inc. | Jackson Richard L. | Director | Dec 04, 2011 | Option Exercise | $6.86 | 1,546 | 10,606 | 27,505 | Dec 07, 2011, 06:43 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Dec 04, 2011 | Option Exercise | $6.86 | 1,546 | 10,606 | 103,755 | Dec 07, 2011, 06:40 PM | |
| ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Dec 01, 2011 | Option Exercise | $6.92 | 6,250 | 43,250 | 105,301 | Dec 05, 2011, 07:21 PM |
Menu